Gaelic Laboratories and Athlone Laboratories agreed terms for Gaelic’s acquisition of Athlone in December 2025. The resulting partnership brought together two experienced and well-respected companies with complementary capabilities to offer customers an enhanced product range, low humidity manufacturing capability and packaging services as well as rapid and cost-effective release testing.
Together, Gaelic and Athlone deliver multiple financial and operational benefits, including cost savings through manufacturing consolidation, revenue growth and increased regulatory advantages.
We offer a wide range of scalable solutions for the testing and production of GMP-approved oral dose Beta-Lactam products from our operations based around the world. Contact us to discuss how we can best meet your needs.
Supply chain efficiencies and manufacturing consolidation has enabled us to enhance our product offerings while generating cost savings, which facilitate increased profit margins and unlocks competitive pricing for consumers.
Based in Ireland and with a strong presence in key markets around the world, we draw on the leading experience of our people and state-of-the-art facilities to power the production of GMP-approved Beta-Lactams on a global scale.
Together, we have a combined workforce of over 120 people, with expertise in both the development and manufacture of Beta-Lactams, and in navigating the often complex international regulatory landscape.
Global Reach
Gaelic Laboratories and Athlone Laboratories offer a wide range of scalable solutions for the testing and production of GMP-approved oral dose Beta-Lactam products from our operations based around the world.
Visit our websites
Brochure
